EyePoint Pharmaceuticals’ EYP-1901: Promising Novel Drug Delivery System

<p class="MsoNormal">In this episode, I chat with <strong>Nancy Lurker,</strong> CEO and board director, about EyePoint Pharmaceuticals and their latest treatments and trials.</p> <p class="MsoNormal"><em>Brought to you by Alcon</em></p> <p class="MsoListParagraphCxSpFirst" style= "text-indent: -.25in; line-height: 106%; mso-list: l0 level1 lfo1;"> <!-- [if !supportLists]--><span style= "font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-style: italic;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';">      </span></span></span> <!--[endif]-->Welcome to another exciting episode of Eye Care insider <strong><em>:13</em></strong></p> <p class="MsoListParagraphCxSpMiddle" style= "text-indent: -.25in; line-height: 106%; mso-list: l0 level1 lfo1;"> <!-- [if !supportLists]--><span style= "font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-style: italic;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';">      </span></span></span> <!--[endif]-->Intro Nancy Lurker <strong><em>:22</em></strong></p> <p class="MsoListParagraphCxSpMiddle" style= "text-indent: -.25in; line-height: 106%; mso-list: l0 level1 lfo1;"> <!-- [if !supportLists]--><span style= "font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-style: italic;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';">      </span></span></span> <!--[endif]-->Lurker’s background <strong><em>:58</em></strong></p> <p class="MsoListParagraphCxSpMiddle" style= "text-indent: -.25in; line-height: 106%; mso-list: l0 level1 lfo1;"> <!-- [if !supportLists]--><span style= "font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-style: italic;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';">      </span></span></span> <!--[endif]-->EyePoint Pharmaceuticals: the origin and transition <strong><e